銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

Aurobindo Pharma
AUROPHARMA ?NSE

Aurobindo Pharma

?1,459.0015.30 (1.06%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
F&O

Performance

Today’s low
1,446.40
Today’s high
1,470.00
52 week low
1,016.10
52 week high
1,550.00
Open price
1,454.00
Previous close
1,443.70
Live volume
4,12,408
Lower circuit
1,299.40
Upper circuit
1,588.00

Fundamentals

Market Cap
?83,813Cr
ROE
9.25%
P/E Ratio(TTM)
23.93
EPS(TTM)
60.31
P/B Ratio
2.21
Dividend Yield
0.28%
Industry P/E
33.86
Book Value
652.39
Debt to Equity
0.21
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
?8,970
+1.55%
Profit (Cr)
?921
+1.21%
02.5k5k7.5k10k
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+5%
3Y CAGR+11%
Profit growthValue
1Y (TTM)+2%
3Y CAGR+10%

About

Aurobindo Pharma is a well-integrated global pharmaceutical firm committed to providing affordable and accessible medicines to patients around the globe. The company's vision is to become a leading and admired global pharmaceutical player, aiming to be ranked within the top 25 companies by the year 2030. Its mission focuses on being the most valued partner to the pharma industry by continuously developing and manufacturing products that meet the highest regulatory standards. The company develops and commercializes a diverse portfolio including generics, specialty products, injectables, active pharmaceutical ingredients, biosimilars, and vaccines across 150+ countries. Leveraging its expertise in large-scale production, the company has positioned itself as a cost-effective provider of Active Pharmaceutical Ingredients (API) for its own and external needs. As the 2nd largest listed Indian pharma company by revenue from operations, it has successfully established itself as a key player in the global market.;
CEO/MD
K. Nithyananda Reddy
Founded in
1986
NSE symbol
AUROPHARMA

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
51.82%
Mutual Funds
17.79%
Foreign Institutions
15.24%
Other Domestic Institutions
8.08%
Retail And Others
7.08%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Laurus LabsLAURUSLABS
?1,376.40
+7.60 (0.56%)
L
    H
    74,008.7983.1313.96
    ?5,355.50
    -16.50 (0.31%)
    L
      H
      64,302.0627.354.65
      Abbott IndiaABBOTINDIA
      ?26,080.00
      -65.00 (0.25%)
      L
        H
        55,539.4335.7911.63
        ?1,582.20
        +38.60 (2.50%)
        L
          H
          39,177.0133.094.86
          Livesquawk ?
          HSBC retains Buy on Aurobindo Pharma with a target price of ?1,580. FDA OAI for Eugia-3 may delay compliance but no incremental business impact.
          Livesquawk ?
          Bernstein maintains 'Market Perform' on Aurobindo Pharma, setting a target price of ?1,498. OAI may freeze ~35 ANDAs, dragging FY27 EPS by 3–3.5% amid quality concerns.
          2026
          21
          May
          Annual Result
          Release date

          17
          Apr
          Buyback
          Ex date

          Offer price?1,475.00
          Buyback window23 Apr ‘26 to 29 Apr ‘26
          Ex date17 Apr ‘26
          Record date17 Apr ‘26
          Announcement date6 Apr ‘26
          Buyback typeTender Offer

          6
          Apr
          Buyback
          Announced

          Offer price?1,475.00
          Buyback window23 Apr ‘26 to 29 Apr ‘26
          Ex date17 Apr ‘26
          Record date17 Apr ‘26
          Announcement date6 Apr ‘26
          Buyback typeTender Offer
          9
          Feb
          Quarterly Result
          Release date
          2025
          5
          Nov
          Quarterly Result
          Release date

          8
          Aug
          Dividend
          Ex date
          ?4.00
          per share

          For each share you hold, you will receive ?4.00
          Dividend amount?4.00 per share
          Dividend TypeInterim
          Ex Date8 Aug ‘25
          Record Date8 Aug ‘25
          Announcement date4 Aug ‘25

          4
          Aug
          Dividend
          Announced
          ?4.00
          per share

          For each share you hold, you will receive ?4.00
          Dividend amount?4.00 per share
          Dividend TypeInterim
          Ex Date8 Aug ‘25
          Record Date8 Aug ‘25
          Announcement date4 Aug ‘25
          4
          Aug
          Quarterly Result
          Release date
          2024

          30
          Jul
          Buyback
          Ex date

          Offer price?1,460.00
          Buyback window5 Aug ‘24 to 9 Aug ‘24
          Ex date30 Jul ‘24
          Record date30 Jul ‘24
          Announcement date18 Jul ‘24
          Buyback typeTender Offer

          18
          Jul
          Buyback
          Announced

          Offer price?1,460.00
          Buyback window5 Aug ‘24 to 9 Aug ‘24
          Ex date30 Jul ‘24
          Record date30 Jul ‘24
          Announcement date18 Jul ‘24
          Buyback typeTender Offer
          Events calendar
          View upcoming events in other stocks

          銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

          xxfseo.com